Xeris Biopharma Holdings, Inc.XERSNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank78
3Y CAGR+22.5%
5Y CAGR+1.2%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+22.5%/yr
vs +12.4%/yr prior
5Y CAGR
+1.2%/yr
Recent acceleration
Acceleration
+10.1pp
Accelerating
Percentile
P78
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$4.74M-10.9%
2024$5.32M+12.0%
2023$4.75M+84.3%
2022$2.58M+723.6%
2021$313000.00-93.0%
2020$4.46M+58.7%
2019$2.81M+74.4%
2018$1.61M+1200.8%
2017$124000.00+2380.0%
2016$5000.00-